Are you a financial expert?Login
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
Signup

VENUSREM

59.3
+0 (0%)
Updated 03:59 06/05 IST

VENUSREM Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for VENUSREM
Disclaimer
0% Bullish
0% Bearish

VENUSREM Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See VENUSREM Share Price Targets >>

VENUSREM Ratings

Long term VENUSREM rating by FrontPage users
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
  • ★
    ★
0/5 (0 Ratings)0
Find answers to all your questions on live VENUSREM message board: Is VENUSREM buy or sell? Should I buy VENUSREM shares? Why are VENUSREM shares falling? Should I invest in VENUSREM stock?

  1. Home
  2. VENUSREM Forum

VENUSREM Share Price Discussion

S
S I R I  @MONEYMAKESMONEY
Reputation: -1,995 • Mar 9 4:03 AM
VENUSREM
Type
Buy
Instrument
VENUSREM
Entry Price
₹30.5
Price@Trade
₹30.5
Target Price
₹80
Stop Price
₹25
Valid Till
Mar 9, 2021 3:20 AM
Margin
₹30.5 approx for 1 Qty
Status
Stoploss Hit
Exit Price
₹24.05
Net P&L
-₹6.45 (-21.15%)
#VENUSREM
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
•
Mar 24 2:38 AM
Update
Stoploss Hit
Exit Price
₹24.05
N
NewsBot @newsbot
Reputation: 3,388 • Oct 16, 2019 2:03 AM
FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
SK Growth Fund acquired 2,45,459 shares of newly listed Vishwaraj Sugar Industries at Rs 60.35 per share.
Moneycontrol
Like
Reply
N
NewsBot @newsbot
Reputation: 3,388 • Feb 18, 2019 4:57 AM
Like
Reply
N
NewsBot @newsbot
Reputation: 3,388 • Nov 16, 2018 4:17 AM
Like
Reply
N
NewsBot @newsbot
Reputation: 3,388 • Nov 15, 2018 5:52 AM
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
Join FrontPage

  • VENUSREM - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization40.91
    Enterprise Value379.37
    Price to Earnings25.4
    Price to Book Value0.12
    Return on Capital Employed0.02
    Return on Equity-0.07
    Face Value10
    Dividend YieldNA

  • VENUSREM Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    May 659.359.359.359.3
    May 556.556.556.556.5
    May 453.8553.8551.9553.85
    Apr 3051.351.351.351.3
    Apr 2948.948.948.948.9

  • VENUSREM Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹38.98
    30 Day Moving Average₹33.95
    50 Day Moving Average₹31.25
    100 Day Moving Average₹27.15
    200 Day Moving Average₹25.79

  • VENUSREM - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue355375.45-0.05
    Operating Profit4375.04-0.43
    Profit Before Tax-231.05-22.9
    Net Income-274.75-6.68

  • VENUSREM - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-19Mar-18 % Change
    Shareholder's Funds341368-0.07
    Total Liabilities3913800.03
    Total Assets732749-0.02

  • VENUSREM - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity52102.56-0.49
    Cash from Investing Activity-11-45.87-0.76
    Cash from Financing Activity-40-56.58-0.29
    Net Cash FlowNA0.11-1

  • VENUSREM - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets-0.040.01
    Return on Equity-0.070.01
    Return on Capital Employed0.020.05

  • VENUSREM - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.21
    3 Year CAGR Growth in Operating Profit-0.51
    3 Year CAGR Growth in EBIDTA-0.5
    3 Year CAGR Growth in Net Income-6.93
    3 Yr CAGR Growth - Diluted EPS-6.48

  • VENUSREM - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.23
    5 Year CAGR Growth in Operating Profit-0.64
    5 Year CAGR Growth in EBIDTA-0.63
    5 Year CAGR Growth in Net Income-1.47
    3 Yr CAGR Growth - Diluted EPS-1.4

  • VENUSREM - Recent News

    keyboard_arrow_down
    NewsBot
    Oct 16, 2019 2:03 AM
    FAL Corp sells entire stake in ICICI Lombard; Axis Trustee offloads 12.93 lakh shares of Rel Cap
    Moneycontrol
    NewsBot
    Feb 18, 2019 4:57 AM
    NewsBot
    Nov 16, 2018 4:17 AM
    NewsBot
    Nov 15, 2018 5:52 AM

  • VENUSREM - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
Privacy•Terms•••
FrontPage © 2020